Of mice and men (and women) and the acylation-stimulating protein pathway

被引:42
作者
Sniderman, AD [1 ]
Maslowska, M [1 ]
Cianflone, K [1 ]
机构
[1] McGill Univ, Royal Victoria Hosp, Ctr Hlth, Mike Rosenbloom Lab Cardiovasc Res, Montreal, PQ H3A 1A1, Canada
关键词
D O I
10.1097/00041433-200006000-00010
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The storage and release of energy by adipocytes is of fundamental biologic importance. Not surprisingly, therefore, the rate at which these processes occur can be modulated by a variety of physiologic molecules. A newly recognized participant is produced by adipocytes themselves: acylation-stimulating protein (ASP), This article focuses on the most recent in-vivo evidence regarding how the ASP pathway may influence energy storage and release. In brief, the rate at which triglycerides are cleared from plasma (i.e. the rate at which they are hydrolysed) is determined by lipoprotein lipase and insulin, which is the principal hormone that regulates lipoprotein lipase, By contrast, the ASP pathway modulates the rate at which fatty acids are taken up and converted to triglycerides by adipocytes. Under certain circumstances, however, reduction of activity of the ASP pathway may negatively impact on the first step of the process. ASP also influences the rate at which fatty acids are released by adipocytes, and it is clear that insulin and ASP interact in a variety of ways that involve energy storage and release. Accordingly, to understand the impact of any intervention on energy storage and release by adipocytes, the effects of both insulin and ASP must be taken into account. Curr Opin Lipidol 11:291-296. (C) 2000 Lippincott Wiliiams & Wilkins.
引用
收藏
页码:291 / 296
页数:6
相关论文
共 19 条
[1]   The influence of oral lipid loads on acylation stimulating protein (ASP) in healthy volunteers [J].
Charlesworth, JA ;
Peake, PW ;
Campbell, LV ;
Pussell, BA ;
O'Grady, S ;
Tzilopoulos, T .
INTERNATIONAL JOURNAL OF OBESITY, 1998, 22 (11) :1096-1102
[2]   Acylation stimulating protein (ASP), an adipocyte autocrine: new directions [J].
Cianflone, K ;
Maslowska, M ;
Sniderman, AD .
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 1999, 10 (01) :31-41
[3]   IMPAIRED RESPONSE OF FIBROBLASTS FROM PATIENTS WITH HYPERAPOBETALIPOPROTEINEMIA TO ACYLATION-STIMULATING PROTEIN [J].
CIANFLONE, KM ;
MASLOWSKA, MH ;
SNIDERMAN, AD .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (03) :722-730
[4]   Lipoprotein lipase and the disposition of dietary fatty acids [J].
Fielding, BA ;
Frayn, KN .
BRITISH JOURNAL OF NUTRITION, 1998, 80 (06) :495-502
[5]  
FRAYN KN, 1993, INT J OBESITY, V17, pS18
[6]   ROLE OF PLASMA TRIGLYCERIDE IN THE REGULATION OF PLASMA LOW-DENSITY-LIPOPROTEIN (LDL) SUBFRACTIONS - RELATIVE CONTRIBUTION OF SMALL, DENSE LDL TO CORONARY HEART-DISEASE RISK [J].
GRIFFIN, BA ;
FREEMAN, DJ ;
TAIT, GW ;
THOMSON, J ;
CASLAKE, MJ ;
PACKARD, CJ ;
SHEPHERD, J .
ATHEROSCLEROSIS, 1994, 106 (02) :241-253
[7]   PREVALENCE OF DYSLIPIDEMIC PHENOTYPES IN ISCHEMIC-HEART-DISEASE (PROSPECTIVE RESULTS FROM THE QUEBEC CARDIOVASCULAR STUDY) [J].
LAMARCHE, B ;
DESPRES, JP ;
MOORJANI, S ;
CANTIN, B ;
DAGENAIS, GR ;
LUPIEN, PJ .
AMERICAN JOURNAL OF CARDIOLOGY, 1995, 75 (17) :1189-1195
[8]   Enhanced triglyceride clearance with intraperitoneal human acylation stimulating protein in C57BL/6 mice [J].
Murray, I ;
Sniderman, AD ;
Cianflone, K .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1999, 277 (03) :E474-E480
[9]   Acylation stimulating protein (ASP) deficiency alters postprandial and adipose tissue metabolism in male mice [J].
Murray, I ;
Sniderman, AD ;
Havel, PJ ;
Cianflone, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (51) :36219-36225
[10]  
Murray I, 1999, J LIPID RES, V40, P1671